Telephone
61.2.8607.5124
Address
Level 19, Suite 1902 821 Pacific Highway Tower A, The Zenith Building Chatswood, New South Wales (NSW) 2067
Description
Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It operates through the North America, Australia and New Zealand geographical segments. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Chatswood, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.18 - 0.88
Trade Value (12mth)
AU$16,992.00
1 week
-2.13%
1 month
-25.81%
YTD
-64.62%
1 year
-65.93%
All time high
4.73
EPS 3 yr Growth
-30.100%
EBITDA Margin
-100.70%
Operating Cashflow
-$17m
Free Cash Flow Return
-120.50%
ROIC
-129.60%
Interest Coverage
-412.50
Quick Ratio
2.80
Shares on Issue (Fully Dilluted)
215m
HALO Sector
Healthcare
Next Company Report Date
20-Feb-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Application for quotation of securities - NXS
×
Application for quotation of securities - NXS |
31 October 23 |
Application for quotation of securities - NXS
×
Application for quotation of securities - NXS |
31 October 23 |
Application for quotation of securities - NXS
×
Application for quotation of securities - NXS |
31 March 22 |
Appendix 3Y - Judith Mitchell
×
Appendix 3Y - Judith Mitchell |
31 July 23 |
Appendix 3Z - Judith Mitchell
×
Appendix 3Z - Judith Mitchell |
31 July 23 |
Notification regarding unquoted securities - NXS
×
Notification regarding unquoted securities - NXS |
31 July 23 |
Notification regarding unquoted securities - NXS
×
Notification regarding unquoted securities - NXS |
31 January 22 |
Enhanced sales & distribution relationship with Zimmer
×
Enhanced sales & distribution relationship with Zimmer |
31 January 22 |
Appendix 4C - 31 December 2021
×
Appendix 4C - 31 December 2021 |
31 January 22 |
Quarterly Activity Report - 31 December 2021
×
Quarterly Activity Report - 31 December 2021 |
31 January 22 |
Investor Presentation - Q4 FY21
×
Investor Presentation - Q4 FY21 |
31 August 23 |
Half Year Results & Capital Raise Update
×
Half Year Results & Capital Raise Update |
31 August 23 |
Half Year Report & Appendix 4D
×
Half Year Report & Appendix 4D |
31 August 23 |
Proposed issue of securities - NXS
×
Proposed issue of securities - NXS |
31 August 23 |
Cleansing Notice
×
Cleansing Notice |
31 August 23 |
Half Year Results & Capital Raise Presentation
×
Half Year Results & Capital Raise Presentation |
30 June 23 |
Director Retirement
×
Director Retirement |
30 January 23 |
Quarterly Activity Report - 31 December 2022
×
Quarterly Activity Report - 31 December 2022 |
30 January 23 |
Appendix 4C - 31 December 2022
×
Appendix 4C - 31 December 2022 |
30 January 23 |
Investor Presentation - Q4 2022
×
Investor Presentation - Q4 2022 |
30 December 22 |
Notice of General Meeting
×
Notice of General Meeting |
30 August 21 |
Half Year Results Investor Presentation
×
Half Year Results Investor Presentation |
29 March 22 |
Appendix 3Y - M Compton
×
Appendix 3Y - M Compton |
29 March 22 |
Appendix 3Y - D Spira
×
Appendix 3Y - D Spira |
29 March 22 |
Appendix 3Y - B Hancox
×
Appendix 3Y - B Hancox |
29 June 23 |
Market Update
×
Market Update |
29 August 23 |
Appendix 3Z - M Compton
×
Appendix 3Z - M Compton |
29 August 23 |
Trading Halt
×
Trading Halt |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.